Search results
Results from the WOW.Com Content Network
The National Defense Authorization Act (NDAA) of 2016 required high-level officials across the federal government to create a national biodefense strategy together. As a result, in 2018 the National Biodefense Strategy was released by President Donald J. Trump. In essence, the strategy comprises the U.S. biological defense program in that it is ...
Develop, implement, and update a comprehensive national biodefense strategy The Vice President should develop a comprehensive national biodefense strategy and implementation plan. 4 Unify biodefense budgeting Congress should mandate the development of a unified budget that defines how the entire biodefense enterprise is funded. 5
In the United States, the National Biodefense Strategy is a White House-issued policy document laying out the federal government's approach to biodefense and biosecurity. The document's most recent version was published in October 2022 by the Biden Administration as the "National Biodefense Strategy and Implementation Plan for Countering ...
The Assistant Secretary is required to develop the Public Health Emergency Medical Countermeasures Enterprise Strategy and Implementation Plan, a coordinated strategy and accompanying implementation plan for medical countermeasures to address chemical, biological, radiological, and nuclear threats.
In the context of the EU's Europe 2020 strategy, Enterprise 2020 provided the foundation for a renewed partnership between business and the European Commission, Council and Parliament. It supported the Commission's goal of "making Europe a pole of excellence on CSR" [ 4 ] and promoting CSR as part of the European strategy for smart, sustainable ...
One year out from Election Day, President Joe Biden ’s reelection campaign is outlining a plan to retain the White House by framing the 2024 race around many of the same themes it used in 2020 ...
The Biomedical Advanced Research and Development Authority (BARDA) is a U.S. Department of Health and Human Services (HHS) office responsible for the procurement and development of medical countermeasures, principally against bioterrorism, including chemical, biological, radiological and nuclear (CBRN) threats, as well as pandemic influenza and emerging diseases.
The United States Army Combat Capabilities Development Command Chemical Biological Center (DEVCOM CBC) is the United States Department of Defense's principal research and development resource for non-medical chemical and biological defense (CB). [1]